华昊中天医药-B股东将股票存入华泰香港 存仓市值1.25亿港元
BIOSTAR PHARM-BBIOSTAR PHARM-B(HK:02563) Zhi Tong Cai Jing·2025-10-15 00:32

Group 1 - The core viewpoint of the article highlights the recent stock deposit by shareholders of Huahao Zhongtian Pharmaceutical-B (02563) into Huatai Hong Kong, with a market value of HKD 125 million, representing 7.91% of the total shares [1] Group 2 - Huahao Zhongtian Pharmaceutical-B reported its interim results for the six months ending June 30, 2025, with a revenue of RMB 14.787 million, reflecting a year-on-year decrease of 55.36% [1] - The company experienced a net loss of RMB 54.041 million, which is a 23.41% reduction compared to the previous year [1] - The basic loss per share was reported at RMB 0.15 [1]